C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/04 (2006.01) A61K 31/517 (2006.01)
Patent
CA 2546754
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
L'invention concerne des composés, comprenant des énantiomères, diastéréomères, solvates résolus ainsi que des sels pharmaceutiquement acceptables de ceux-ci. Ces composés comprennent la formule: A-L-CR, dans laquelle CR représente un groupe central cyclique, L représente un groupe de liaison et A est tel que défini dans le descriptif. L'invention concerne également des procédés permettant d'utiliser ces composés en tant qu'inhibiteurs de la protéine kinase AKT ainsi que pour le traitement de maladies hyperprolifératives telles que le cancer.
Bernacki April L.
Blake James
Han Yongxin
Josey John
Kallan Nicholas C.
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Akt protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1492011